Reneo Pharmaceuticals Inc. - RPHM Net earnings per one share for the last twelve months

Reneo Pharmaceuticals Inc. (RPHM) - corporate logo

Reneo Pharmaceuticals (RPHM) relies on outsourcing the production of molecules for myopathies. The company has prioritized the implementation of ESG standards in biopharmaceuticals and strict adherence to bioethics. The annual EPS TTM YoY trend confirms the dynamics of these processes, where -18.60 determines the current status of the parameter. In the long term, the creation of unique orphan drugs will provide the firm with significant pricing power in the market.

RPHM: reneopharma.com Net earnings per share for the last 12 months 02/11/2024 - 02/20/2024

Reneo Pharmaceuticals - analytical breakdowns and key metrics (RPHM)

Fundamental company valuation:RPHM - Reneo Pharmaceuticals Inc.
Brand item of Reneo Pharmaceuticals, Inc

This indicator measures the rate of change in net income per share over a rolling twelve-month period. The calculation is based on comparing current total income with the same interval from the previous year to neutralize seasonality. By analyzing the annual net income per share growth rate (ttm), an investor assesses real operational efficiency. For Reneo Pharmaceuticals (RPHM), this trend reflects the financial consequences of asset restructuring. Current fluctuations on the chart confirm the company's transition to an external licensing strategy for new molecules.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Applied Therapeutics APLT|RNTX - Earnings per share for the last twelve months|Net earnings per share for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Net earnings per share for the last 12 months|Chemomab Therapeutics Ltd - Earnings per share for the trailing year|Net earnings per share for the last 12 months SRXH|Earnings per share for the last twelve months PLRZ|Net earnings per share (EPS TTM) AEZS|Earnings per share for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)